Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression
- 20 July 2024
- journal article
- review article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 99
Abstract
No abstract availableKeywords
This publication has 220 references indexed in Scilit:
- Positioning determines function: Wandering PKM2 performs different roles in tumor cellsCell Biology International, 2023
- Advanced Nanomaterials for the Diagnosis and Treatment of Renal Cell CarcinomaAdvanced NanoBiomed Research, 2023
- PD‐1/PD‐L1 inhibitors‐based treatment for advanced renal cell carcinoma: Mechanisms affecting efficacy and combination therapiesCancer Medicine, 2021
- A Hypoxia‐Responsive Albumin‐Based Nanosystem for Deep Tumor Penetration and Excellent Therapeutic EfficacyAdvanced Materials, 2019
- Modeling and closed‐loop control of particle size and initial burst of PLGA biodegradable nanoparticles for targeted drug deliveryJournal of Applied Polymer Science, 2017
- Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug‐Loaded Magnetic Solid Lipid NanoparticlesAdvanced Healthcare Materials, 2015
- Engineered Nanoparticles for Drug Delivery in Cancer TherapyAngewandte Chemie International Edition, 2014
- Racial difference in histologic subtype of renal cell carcinomaCancer Medicine, 2013
- Analgesic use and the risk of kidney cancer: A meta‐analysis of epidemiologic studiesInternational Journal of Cancer, 2013
- Molecular stability of chitosan in acid solutions stored at various conditionsJournal of Applied Polymer Science, 2007